Panacea Biotec Limited, a inactive for e-filing public limited company, was established on 02 February 1984 in Na, Delhi, India. Engaging in drug formulation & development within the pharma sector, it holds CIN: U24233DL1984PLC017475. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹2.00 M and a paid-up capital of ₹20.00 K .
It is based at 1584/6 M V Building 1St Floorchandni Chowk Delhi 110006, Na, Delhi.
U24233DL1984PLC017475
017475
02 February 1984
₹2.00 M
₹20.00 K
Roc Delhi
Unlisted
Inactive For E-Filing
Explore comprehensive insights into Panacea Biotec Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Enhance accessibility to Panacea Biotec's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
******* |
******* |
******* |
******* |
||
| Revenue from Operations |
|
******* |
******* |
******* |
******* |
||
| Total Assets |
|
******* |
******* |
******* |
******* |
||
| Profit or Loss |
|
*******
|
*******
|
*******
|
*******
|
||
| Net Worth |
|
*******
|
*******
|
*******
|
*******
|
||
| EBITDA |
|
******* |
******* |
******* |
******* |
Discover detailed financial data and - Unlock financial today!
Unlock access to Panacea Biotec's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
| FY (2024) | FY (2023) | FY (2022) | FY (2021) | FY (2020) | |
|---|---|---|---|---|---|
| Promoters | 92.83 | 94.62 | 94.55 | 94.55 | 94.55 |
| Public | 4.10 | 3.89 | 3.95 | 3.96 | 3.98 |
| Others | 3.07 | 1.49 | 1.50 | 1.49 | 1.47 |
Reveal ownership structures and financial performance - Get instant access now!
Unlock and access historical data on people associated with Panacea Biotec, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
| Employee Date | Number of Employees |
|---|---|
| 2020 | 78,000 |
| 2021 | 80,500 |
| 2022 | 83,200 |
| 2023 | 86,000 |
| 2024 | 89,500 |
| 2025 | 92,000 |
Gain comprehensive insights into the Deals and Valuation data of Panacea Biotec, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Panacea Biotec's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Explore deal ratings and alerts - Get instant access now!
Progress on Panacea Biotec Limited was registered on 02 Feb 1984 with Roc Delhi & aged 42 years 2 months as per MCA records. was documented.
Explore recent activity and updates - View Recent Activity
Six in one has the potential of over 250 million doses in next 3-4 years with a market size of over $1.25 Billion annually..
India Business News: New Delhi, Dec 27 () Drug firm Panacea Biotec has filed a review petition against the grant of a patent with regard to a pneumonia vaccine to the US-b.
"The company's first-to-file abbreviated new drug application (ANDA) of Prasugrel 5 mg and 10 mg tablets has been approved by the US Food and Drug Administration (USFDA)," Panacea Biotec said in a BSE filing..
Mumbai: Panacea Biotec said that it has received the Certificate of GMP compliance from State Service of Ukraine on Medicines and Drugs Control with Manufacturing Authorization for 22 medicinal... .
Panacea Biotec signs an agreement with Canada's Apotex to launch Prasugrel 5mg and 10mg tablets, used for the treatment of certain coronary diseases, in the US.
Explore news and more updates - View Recent News
The CIN of Panacea Biotec Limited is U24233DL1984PLC017475.
Panacea Biotec Limited is headquartered at 1584/6 M V Building 1St Floorchandni Chowk Delhi 110006, Na, Delhi.
Panacea Biotec Limited was incorporated on 02 February 1984.
The primary industry of Panacea Biotec Limited is Pharma.
Panacea Biotec Limited is unlisted.
The authorized capital of Panacea Biotec Limited is ₹2.00 M, and the paid-up capital is ₹20.00 K .
+91-XXXXXXXXXX